APA (7th ed.) Citation

Wang, Y., Wang, Q., Wang, M., Wang, X., Liu, Q., Lv, S., . . . Liu, G. (2024). Epigallocatechin‐3‐Gallate Ameliorates Diabetic Kidney Disease by Inhibiting the TXNIP/NLRP3/IL‐1β Signaling Pathway. Food science & nutrition, 12(12), 10800-10815. https://doi.org/10.1002/fsn3.4617

Chicago Style (17th ed.) Citation

Wang, Yinghui, Qimeng Wang, Mingming Wang, Xueling Wang, Qingzhen Liu, Shasha Lv, Huibin Nie, and Gang Liu. "Epigallocatechin‐3‐Gallate Ameliorates Diabetic Kidney Disease by Inhibiting the TXNIP/NLRP3/IL‐1β Signaling Pathway." Food Science & Nutrition 12, no. 12 (2024): 10800-10815. https://doi.org/10.1002/fsn3.4617.

MLA (9th ed.) Citation

Wang, Yinghui, et al. "Epigallocatechin‐3‐Gallate Ameliorates Diabetic Kidney Disease by Inhibiting the TXNIP/NLRP3/IL‐1β Signaling Pathway." Food Science & Nutrition, vol. 12, no. 12, 2024, pp. 10800-10815, https://doi.org/10.1002/fsn3.4617.